Vertex Pharmaceuticals Inc / Ma

RHUMBLINE ADVISERS VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

431,262

Value ($000)

195,517

Weight

0.2%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	195,517	0.2%	431,262	12/31/2025
2025 Q3	11/6/2025	175,426	0.1%	447,928	9/30/2025
2025 Q2	8/12/2025	202,286	0.2%	454,372	6/30/2025
2025 Q1	5/29/2025	218,669	0.2%	451,031	3/31/2025
2024 Q4	5/29/2025	178,139	0.2%	442,361	12/31/2024
2024 Q3	11/12/2024	209,145	0.2%	449,696	9/30/2024
2024 Q2	8/1/2024	214,629	0.2%	457,905	6/30/2024
2024 Q1	5/9/2024	193,633	0.2%	463,227	3/31/2024
2023 Q4	2/8/2024	186,554	0.2%	458,488	12/31/2023
2023 Q3	11/9/2023	161,265	0.2%	463,751	9/30/2023
2023 Q2	8/8/2023	163,049	0.2%	463,326	6/30/2023
2023 Q1	5/11/2023	141,917	0.2%	450,431	3/31/2023
2022 Q4	2/14/2023	123,233	0.2%	426,737	12/31/2022
2022 Q3	11/10/2022	118,185	0.2%	408,183	9/30/2022
2022 Q2	8/11/2022	111,587	0.2%	395,995	6/30/2022
2022 Q1	5/12/2022	98,990	0.1%	379,316	3/31/2022
2021 Q4	2/10/2022	86,142	0.1%	392,266	12/31/2021
2021 Q3	11/12/2021	69,885	0.1%	385,274	9/30/2021
2021 Q2	8/5/2021	80,804	0.1%	400,756	6/30/2021
2021 Q1	5/6/2021	108,873	0.1%	506,646	3/31/2021
2020 Q4	2/10/2021	123,429	0.2%	522,252	12/31/2020
2020 Q3	11/12/2020	141,477	0.2%	519,907	9/30/2020
2020 Q2	8/13/2020	154,609	0.3%	532,564	6/30/2020
2020 Q1	5/6/2020	119,923	0.3%	503,986	3/31/2020
2019 Q4	2/5/2020	109,835	0.2%	501,645	12/31/2019
2014 Q2	8/6/2014	34,245	0.1%	361,689	6/30/2014
2014 Q1	5/6/2014	25,248	0.1%	357,011	3/31/2014
2013 Q4	2/3/2014	26,062	0.1%	350,766	12/31/2013